SIRT6 and type 2 diabetes mellitus: Incretin treatment attenuates diabetic atherosclerosis in T2DM patients; however, SIRT6-attenuated inflammation in atherosclerotic lesions was regarded to potentiate the therapeutic effect of incretin [327].